Table 1

Baseline data between IRDs and nIRDs in community acquired COVID-19 (n=68)

ParameterIRDnIRD
COVID-19 positive (n, %)40 (58.9)28 (41.2)
Age in years (mean, SD)51.8 (16.5)56.46 (13.6)
Female (n, %)31 (77.5)20 (71.4)
CVS disease (n, %)4 (10)10* (35.7)
BMI>30 (n, %)11 (27.5)8 (28.6)
T2DM (n, %)3 (7.5)1 (3.6)
GC (n, %)2 (5)1 (3.6)
Incidence (per 100 000)884940
DiagnosisRA 14Costochondritis 1
SLE 4Fracture 9
Sjogren’s 2Fibromyalgia 6
JIA 2Gout 1
HUVS 1EDS 1
uCTD 5OA 8
PMR 1Functional 1
AS 4Mechanical 1
  • *P<0.05

  • AS, ankylosing spondylitis; BMI, body mass index; CVS, cardiovascular disease; EDS, Ehlers Danlos syndrome; GC, glucocorticosteriods; HUVS, hypocomplementemic urticarial vasculitis syndrome; IRD, inflammatory rheumatic disease; JIA, juvenile idiopathic arthritis; nIRD, non-inflammatory rheumatic disease; OA, osteoarthritis; PMR, polymyalgia rheumatica; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; T2DM, type 2 diabetes mellitus; uCTD, undifferentiated connective tissue disease.